Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease
- PMID: 22792372
- PMCID: PMC3394734
- DOI: 10.1371/journal.pone.0040570
Relationship between periodontitis-related antibody and frequent exacerbations in chronic obstructive pulmonary disease
Abstract
Background: To identify patients with chronic obstructive pulmonary disease (COPD) who are susceptible to frequent exacerbations is important. Although periodontitis aggravated by poor oral hygiene might increase the risk of lower respiratory tract infection, the relationship between periodontitis and COPD exacerbations remains unknown. This prospective cohort study investigates the relationship between periodontitis-related antibody and exacerbation frequency over a one-year period.
Methods: We assessed an IgG antibody titer against Porphyromonas gingivalis, which is a major pathogen of periodontitis, and then prospectively followed up 93 individuals over one year to detect exacerbations.
Results: The numbers of exacerbations and the rate of individuals with frequent exacerbations (at least two per year) were significantly lower in patients with higher IgG titer than those with normal IgG titer (0.8 vs. 1.2 per year, p= 0.045 and 14.3 vs. 38.6%, p= 0.009, respectively). Multivariate logistic regression analysis showed that being normal-IgG titer for periodontitis-related antibody significantly increased the risk of frequent exacerbations (relative risk, 5.27, 95% confidence interval, 1.30-25.7; p = 0.019) after adjusting for other possible confounders, such as a history of exacerbations in the past year, disease severity, COPD medication and smoking status.
Conclusions: Normal-IgG titer for periodontitis-related antibody can be an independent predictor of frequent exacerbations. Measuring periodontitis-related antibody titers might be useful to identify patients with susceptibility to frequent exacerbations so that an aggressive prevention strategy can be designed.
Conflict of interest statement
Figures
Similar articles
-
Antibody reactive with Porphyromonas gingivalis hemagglutinin in chronic and generalized aggressive periodontitis.J Periodontal Res. 2004 Aug;39(4):263-8. doi: 10.1111/j.1600-0765.2004.00735.x. J Periodontal Res. 2004. PMID: 15206920
-
Avidity and titer of immunoglobulin G subclasses to Porphyromonas gingivalis in adult periodontitis patients.Oral Microbiol Immunol. 1992 Dec;7(6):332-7. doi: 10.1111/j.1399-302x.1992.tb00632.x. Oral Microbiol Immunol. 1992. PMID: 1338600
-
Relationship between serum antibody levels and subgingival colonization of Porphyromonas gingivalis in patients with various types of periodontitis.J Periodontol. 1997 Jul;68(7):618-25. doi: 10.1902/jop.1997.68.7.618. J Periodontol. 1997. PMID: 9249632
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
[Possible correlations between periodontitis and chronic obstructive pulmonary disease. Review of the literature].Fogorv Sz. 2011 Sep;104(3):87-92. Fogorv Sz. 2011. PMID: 22039714 Review. Hungarian.
Cited by
-
Impact of Non-surgical Periodontal Therapy on Pulmonary functions, Periodontal Health and Salivary Matrix Metalloproteinase-8 of COPD Patients with Chronic Periodontitis: A Clinico-biochemical Study.Turk Thorac J. 2021 Jul;22(4):324-332. doi: 10.5152/TurkThoracJ.2021.20096. Turk Thorac J. 2021. PMID: 35110250 Free PMC article.
-
Porphyromonas gingivalis outside the oral cavity.Odontology. 2022 Jan;110(1):1-19. doi: 10.1007/s10266-021-00647-8. Epub 2021 Aug 19. Odontology. 2022. PMID: 34410562 Review.
-
Periodontal Inflammation as a Modifiable Risk Factor for COPD Exacerbations in the Indian Population: A Prospective Cohort Study.J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S4006-S4009. doi: 10.4103/jpbs.jpbs_1223_24. Epub 2024 Dec 27. J Pharm Bioallied Sci. 2024. PMID: 39926746 Free PMC article.
-
Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries.Int J Chron Obstruct Pulmon Dis. 2018 Oct 26;13:3459-3471. doi: 10.2147/COPD.S165187. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 30464435 Free PMC article. Review.
-
The impact of gingivitis reduction on lung function: a randomized trial under intensified oral hygiene.Trials. 2023 Feb 23;24(1):139. doi: 10.1186/s13063-023-07135-0. Trials. 2023. PMID: 36823669 Free PMC article. Clinical Trial.
References
-
- Global strategy for diagnosis, management, and prevention of COPD updated 2010. Available from. http://www.goldcopd.com.
-
- Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138. - PubMed
-
- Stoller JK. Clinical practice. Acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;346:988–994. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous